4//SEC Filing
Yarema Kristin 4
Accession 0001209191-23-024103
CIK 0001661460other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 4:49 PM ET
Size
7.4 KB
Accession
0001209191-23-024103
Insider Transaction Report
Form 4
Yarema Kristin
President and CEO
Transactions
- Award
Common Stock
2023-04-11+356,836→ 356,836 total - Award
Employee Stock Option (Right to Buy)
2023-04-11+498,325→ 498,325 totalExercise: $2.62Exp: 2033-04-10→ Common Stock (498,325 underlying)
Footnotes (2)
- [F1]Represents shares issuable upon the vesting of restricted stock units granted pursuant to the Issuer's 2022 Inducement Plan. The RSUs are scheduled to vest in four equal annual installments.
- [F2]12.5% of the shares subject to the stock option will vest and become exercisable on the six-month anniversary of the grant date listed in column 3 above, and the remaining shares will vest in 42 equal monthly installments thereafter.
Documents
Issuer
Poseida Therapeutics, Inc.
CIK 0001661460
Entity typeother
Related Parties
1- filerCIK 0001803794
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 4:49 PM ET
- Size
- 7.4 KB